1.09
-0.03(-2.68%)
Currency In USD
| Previous Close | 1.12 |
| Open | 1.18 |
| Day High | 1.21 |
| Day Low | 1.09 |
| 52-Week High | 2.67 |
| 52-Week Low | 0.93 |
| Volume | 49,045 |
| Average Volume | 50,715.8 |
| Market Cap | 32.8M |
| PE | -5.45 |
| EPS | -0.2 |
| Moving Average 50 Days | 1.32 |
| Moving Average 200 Days | 1.38 |
| Change | -0.03 |
If you invested $1000 in Dyadic International, Inc. (DYAI) 10 years ago, it would be worth $981.98 as of May 07, 2025 at a share price of $1.09. Whereas If you bought $1000 worth of Dyadic International, Inc. (DYAI) shares 5 years ago, it would be worth $171.65 as of May 07, 2025 at a share price of $1.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
GlobeNewswire Inc.
May 01, 2025 7:00 PM GMT
JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and ani
Dyadic to Present at World Vaccine Congress | Washington
GlobeNewswire Inc.
Apr 16, 2025 6:00 PM GMT
JUPITER, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company that utilizes its microbial production platforms to develop commercial cell lines f
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
GlobeNewswire Inc.
Mar 20, 2025 12:30 PM GMT
JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and a